Medical News
Addiction
Allergies
Alternative Medicine
Asthma
Cancer
Cardiology
Chiropractic
Dental
Dermatology
Diabetes
Emergency
Family Medicine
General
Geriatrics
Hospitals
Infectious Diseases
Internal Medicine
Managed Care / HMO
Medical Products
Mental Health
Neurology
Nursing
Nutrition
OB / GYN
Pediatrics
Pharmaceuticals
Physical Therapy
Plastic Surgery
Psychology
Radiology / Imaging
Research
Sports Medicine
Surgery
Vision

Xcelience Expanding Operations

The Tampa-based contract research organization acquires a brand new building.

Tampa, FL (PRWEB) July 23, 2007 -- Xcelience, a leading source for formulation development and clinical trial manufacturing, has expanded its ability to provide clients timely and efficient drug development solutions through the acquisition of an additional 24,000 sq ft building.

"The demand for Xcelience's services in the areas of Formulation Development and support to the Pharmaceutical Industries' demand of early clinical development needs has been a major driver for the current growth of Xcelience. This expansion will pave the way for continuing to support our clients' drug development needs into the future with their current and future projects," states Randall H. Guthrie, Vice President of Xcelience.

The recently acquired property, located less than 0.6 miles away from the current location, will accommodate Xcelience's growth by doubling its capacity. "Our sponsors' trust in our work has grown our business to the point of needing more space. We will continue to operate out of both facilities so as not to interrupt our operations," said Derek Hennecke, CEO.

About Xcelience
Xcelience is the premier source for unsurpassed quality in drug development services. The company brings together the industry's most experienced and talented scientists, consistently and efficiently moving compounds through the research and development continuum to regulatory approval.

Since 1997, the Tampa-based laboratory has been developing formulations for clients throughout the pharmaceutical industry. Xcelience's unique corporate structure creates project teams that work intensively with each client, bringing an extension of their own organization into the
Xcelience lab.

The lab uses only state-of-the-art equipment, highlighted by the patented Xcelodose® which fills API directly to capsules (Xcelodose® is a registered trademark of Capsugel). This and other technologies give Xcelience unparalleled speed to market without compromising its absolute commitment to quality.

Located less than five minutes from Tampa International Airport, both labs are close to accommodations, and convenient for clients with time-sensitive needs.

###

Simillar Articles

Xcelience Expands its Early Drug Development Capabilities
The Tampa-based CRO is first to acquire next generation Xcelodose.
Xcelience Employs CFS1200 Capsule Filling and Sealing Machine
Xcelience's implementation of the CFS1200 will allow its formulation scientists the opportunity to accelerate the drug development timeframe.
Xcelience Launches New Service to Enhance Its Preformulation & Formulation Capabilities
The Tampa-based CRO continues its perpetual growth with new XRD support
Xcelience and Its CEO Are Finalists for Three Prestigious Business Awards
The Tampa-based CRO and its chief executive are voted as best company and CEO of the year.
Xcelience Debuts its Innovative and Interactive Forum: XpertXchange™
XpertXchange will initiate dialogue between Xcelience scientists and drug development professionals.
Home Terms of Use Privacy Policy Contact Us